## **Core Concept**
Primary open-angle glaucoma (POAG) is a chronic condition characterized by a slow clogging of the drainage canals, resulting in increased eye pressure. The management of POAG typically involves medications that decrease intraocular pressure (IOP) to prevent optic nerve damage. Various classes of drugs are used, including prostaglandin analogs, beta-blockers, alpha agonists, carbonic anhydrase inhibitors, and miotics.

## **Why the Correct Answer is Right**
The correct answer, **Pilocarpine**, is a muscarinic receptor agonist (miotic) that increases the outflow of aqueous humor by contracting the ciliary muscle and thereby opening the trabecular meshwork. It is often considered a last resort in the management of POAG for several reasons: its dosing regimen (multiple times a day), potential for ocular side effects (e.g., miosis, brow ache), and the availability of more effective and better-tolerated medications. However, it remains a valuable option, especially in certain cases where other treatments are ineffective or not tolerated.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in the management of POAG, the goal is to reduce intraocular pressure to a level that prevents progressive optic neuropathy while minimizing side effects. **Pilocarpine**, as a miotic agent, is particularly useful in certain scenarios but is generally not a first-line treatment due to its side effect profile and dosing frequency.

## **Correct Answer:** D. Pilocarpine